We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

49 hedge funds and large institutions have $49.4M invested in Calithera Biosciences, Inc in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

6% less funds holding

Funds holding: 52 → 49 (-3)

15% less capital invested

Capital invested by funds: $58M → $49.4M (-$8.55M)

25% less call options, than puts

Call options by funds: $216K | Put options by funds: $287K

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
16
Reduced
9
Closed
12
Calls
$216K
Puts
$287K
Net Calls
-$71K
Net Calls Change
+$134K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$2.96M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.39M
3
NLVP
New Leaf Venture Partners
New York
+$1.06M
4
BIT
BlackRock Institutional Trust
California
+$1.02M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$965K

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$2.39M
2
EMG
Ellington Management Group
Connecticut
-$570K
3
CS
Candriam SCA
Luxembourg
-$227K
4
Goldman Sachs
Goldman Sachs
New York
-$168K
5
BC
Birchview Capital
Vermont
-$141K
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
26
T. Rowe Price Associates
Maryland
$94K +$3.63K +28 +3%
TA
27
Teachers Advisors
New York
$86K – – –
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$75K +$4.79K +37 +6%
HCM
29
Howland Capital Management
Massachusetts
$73K – – –
BG
30
BlackRock Group
United Kingdom
$69K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$55K – – –
BA
32
BlackRock Advisors
Delaware
$44K – – –
NFA
33
Nationwide Fund Advisors
Ohio
$39K – – –
AIG
34
American International Group
New York
$35K – – –
AC
35
Amici Capital
New York
$35K – – –
AIM
36
Advantage Investment Management
Iowa
$34K +$40.8K +315 New
Citadel Advisors
37
Citadel Advisors
Florida
$24K +$28.4K +219 New
Wells Fargo
38
Wells Fargo
California
$20K -$17.9K -138 -42%
MCM
39
Mazama Capital Management
Oregon
$20K +$23.8K +184 New
TRCT
40
Tower Research Capital (TRC)
New York
$16K +$19.2K +148 New
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$14.6K +$11.4K +88 +191%
Morgan Stanley
42
Morgan Stanley
New York
$14K +$9.72K +75 +147%
Simplex Trading
43
Simplex Trading
Illinois
$10K +$4.02K +31 +50%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$2K -$1.43K -11 -34%
Citigroup
45
Citigroup
New York
$1K -$130 -1 -14%
BlackRock
46
BlackRock
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
NI
48
Numeric Investors
Massachusetts
– -$2.39M -16,767 Closed
EMG
49
Ellington Management Group
Connecticut
– -$570K -3,994 Closed
Goldman Sachs
50
Goldman Sachs
New York
– -$168K -1,179 Closed
1
2
3

CALA Hedge Fund Activity: Q3 2015 in Review

49 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2015, worth a combined $49.4M — down 15% from $58M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CALA and 9 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 16 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $2.96M. The largest seller was Numeric Investors, exiting entirely with an estimated $2.39M sold.

  • 49 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2015, down from 52 in Q2 2015.
  • Funds reported $49.4M of Calithera Biosciences, Inc stock for Q3 2015, down 15% quarter-over-quarter.
  • 9 funds opened new Calithera Biosciences, Inc positions in Q3 2015 and 12 closed out, a net change of -3 holders.
  • The largest Calithera Biosciences, Inc buyer in Q3 2015 was BVF Inc, an estimated $2.96M added.
  • The largest Calithera Biosciences, Inc seller in Q3 2015 was Numeric Investors, an estimated $2.39M sold.

Based on aggregated 13F filings for Q3 2015.